Grufity logoGrufity logo

EHC

56.51USD-0.61(-1.07%)Delayedas of 28 Nov 2022, 01:04 pm

Encompass Health Corp

Market Summary

USD56.51-0.61Delayedas of 28 Nov 2022, 01:04 pm
-1.07%

EHC Alerts

EHC Stock Price

RSI Chart

Valuation

Market Cap

5.5B

Price/Earnings

16.63

Price/Sales

1.03

Price/Cashflow

7.13

MarketCap/EBT

10.01

Price/Sales

Profitability

EBT Margin

10.34%

Return on Equity

16.37%

Return on Assets

4.63%

Fundamentals

Revenue

Revenue (TTM)

5.1B

Revenue Y/Y

-15.2%

Revenue Q/Q

-18.11%

Earnings

Earnings (TTM)

273.2M

Earnings Y/Y

-54.6%

Earnings Q/Q

-6.78%

Price Action

52 Week Range

41.9859.06
(Low)(High)

Last 7 days

2%

Last 30 days

11.8%

Last 90 days

16.7%

Trailing 12 Months

15.7%

Financial Health

Current Ratio

1.24

Debt/Equity

1.61

Debt/Cashflow

0.24

Investor Care

Dividend Yield

1.74%

Dividend/Share (TTM)

0.88

Buy Backs (1Y)

20.15%

Diluted EPS (TTM)

2.36

Peers (Alternatives to Encompass Health)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
64.2B
59.8B
10.07% 0.52%
9.86
1.07
3.14% -18.15%
20.3B
15.3B
5.27% -14.19%
10.19
1.29
-7.83% -36.44%
16.9B
10.3B
3.87% 1.66%
13.7
1.64
-6.81% -43.45%
MID-CAP
8.6B
13.2B
21.36% 3.30%
11.12
0.66
6.21% -30.27%
6.4B
11.6B
-25.57% -27.53%
7.72
0.55
0.49% -29.54%
5.5B
5.1B
11.80% 15.74%
16.63
1.03
1.10% -32.81%
4.8B
19.0B
8.28% -41.11%
3.32
0.25
-2.58% 58.43%
3.2B
6.2B
-5.53% -19.29%
14.06
0.48
12.16% -46.21%
2.5B
2.4B
3.26% -38.55%
-84.36
1.03
12.91% 52.07%
SMALL-CAP
1.7B
928.7M
-3.94% 7.62%
38.16
1.87
11.11% 9.39%
1.1B
1.4B
-9.84% -38.20%
47.05
0.81
6.94% -77.50%
849.9M
2.8B
-31.29% -52.06%
-9.25
0.32
-6.67% -377.23%
408.1M
12.3B
55.65% -73.83%
-2.14
0.03
0.40% -152.47%
6.3M
41.9M
-3.09% -59.05%
-3.12
0.15
2.62% -160.05%

Financials for Encompass Health

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue-3.7%5,0725,2685,2255,1225,017
  S&GA Expenses-2.8%207213207197175
Earnings Before Taxes-9.8%491545631657660
Net Income-16.7%273328392412407
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-22.7%5,4767,0826,9446,8656,722
  Current Assets-28.9%7341,032950921910
    Cash Equivalents-67.9%60187945595
  Goodwill-49.2%1,2472,4572,4572,4282,418
Liabilities-17.8%3,7284,5384,4524,4664,428
  Current Liabilities-27.6%605835755749794
  Long Term Debt-15.9%2,7193,2343,2213,2443,142
Shareholder's Equity-39.2%1,2172,0031,9741,9111,843
  Retained Earnings-142----
  Additional Paid-In Capital-2,290----
Shares Outstanding-20.4%99125124--
Minority Interest-1.1%493498475446418
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-14.1%657765776716872
  Share Based Compensation-6.1%3234383326
Cashflow From Investing-8.5%-641.30-591.00-693.80-666.30-588.30
Cashflow From Financing-54.1%-86.90-56.40-223.50-240.10-636.60
  Dividend Payments0%112112112112112
  Buy Backs-100.0%02
* denotes actual numbers (not divided by Millions)

Risks

What is the probability of a big loss on EHC?

61.5%


Probability that Encompass Health stock will be more than 20% underwater in next one year

31.9%


Probability that Encompass Health stock will be more than 30% underwater in next one year.

0%


Probability that Encompass Health stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does EHC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Encompass Health was unfortunately bought at previous high price.

Returns

Cumulative Returns on EHC

14.8%


10-Year Cumulative Returns

12.5%


7-Year Cumulative Returns

9.6%


5-Year Cumulative Returns

1.8%


3-Year Cumulative Returns

What are the long-term rolling returns for EHC?

FIve years rolling returns for Encompass Health.

Which funds bought or sold EHC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Eagle Bay Advisors LLC
REDUCED
-47.18
-27,115
30,000
0.02%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
695,000
695,000
0.01%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
-1,735,000
5,673,000
0.01%
2022-11-17
BROOKS, MOORE & ASSOCIATES, INC.
REDUCED
-20.38
-49,000
206,000
0.17%
2022-11-17
M&T Bank Corp
-
-
-216,000
-
-%
2022-11-17
CENTRAL TRUST Co
REDUCED
-20.38
-
2,000
-%
2022-11-16
Retirement Systems of Alabama
REDUCED
-20.63
-2,975,000
12,236,000
0.06%
2022-11-16
Neo Ivy Capital Management
SOLD OFF
-100
-140,000
-
-%
2022-11-16
Front Row Advisors LLC
NEW
-
1,000
1,000
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-251,000
-
-%

1–10 of 43

Latest Funds Activity

Are funds buying EHC calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own EHC

Encompass Health News

Armenian Reporter

Mackenzie Financial Corp Takes Position in Encompass Health Co. (NYSE:EHC).32 hours ago

GuruFocus.com

EHC Fair Value

Recent SEC filings of Encompass Health

View All Filings
Date Filed Form Type Document
Nov 14, 2022
8-K
Current Report
Nov 02, 2022
10-Q
Quarterly Report
Nov 01, 2022
4
Insider Trading
Oct 26, 2022
8-K
Current Report
Oct 19, 2022
4
Insider Trading
Oct 19, 2022
4
Insider Trading
Oct 19, 2022
4
Insider Trading
Oct 19, 2022
4
Insider Trading
Oct 19, 2022
4
Insider Trading
Oct 19, 2022
4
Insider Trading

Latest Insider Trading transactions for EHC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-10-31
CARMICHAEL GREG D
BOUGHT
100,046
54.67
1,830
-
2022-10-18
CHIDSEY JOHN
ACQUIRED
42,171
49.73
848
-
2022-10-18
Reidy Christopher R
ACQUIRED
25,197.9
49.7
507
-
2022-10-17
KATZ LESLYE G
ACQUIRED
-
-
123
-
2022-10-17
CORRELL DONALD L
ACQUIRED
-
-
292
-
2022-10-17
CHIDSEY JOHN
ACQUIRED
-
-
279
-
2022-10-17
Maryland Patricia Anne
ACQUIRED
-
-
27
-
2022-10-17
O'Connor Kevin J.
ACQUIRED
-
-
10
-
2022-10-17
Williams Terrance
ACQUIRED
-
-
27
-
2022-10-17
CARMICHAEL GREG D
ACQUIRED
-
-
27
-

1–10 of 50

Mark J. Tarr
43400
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of April 11, 2022, it operated 147 hospitals, 251 home health locations, and 96 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

EHC Income Statement

2022-09-30
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Statement Of Comprehensive Income And Income Statement [Abstract]    
Net operating revenues$ 1,089.5$ 1,010.8$ 3,211.3$ 2,972.4
Operating expenses:    
Salaries and benefits605.6537.01,778.91,554.8
Other operating expenses172.0151.4500.3442.2
Occupancy costs12.414.541.644.5
Supplies51.146.7148.2136.0
General and administrative expenses37.938.9111.5123.7
Depreciation and amortization62.155.5180.3162.9
Total operating expenses941.1844.02,760.82,464.1
Loss on early extinguishment of debt0.00.01.41.0
Interest expense and amortization of debt discounts and fees38.239.9138.2124.3
Other expense (income)3.6(0.5)13.6(4.8)
Equity in net income of nonconsolidated affiliates(0.7)(0.9)(2.6)(2.5)
Income from continuing operations before income tax expense107.3128.3299.9390.3
Provision for income tax expense21.826.268.279.4
Income from continuing operations85.5102.1231.7310.9
(Loss) income from discontinued operations, net of tax(18.5)24.616.790.6
Net and comprehensive income67.0126.7248.4401.5
Net and comprehensive income67.0126.7248.4401.5
Less: Net income attributable to noncontrolling interests included in continuing operations(21.6)(26.3)(65.5)(79.6)
Less: Net income attributable to noncontrolling interests included in discontinued operations0.0(0.4)(1.3)(1.3)
Net income attributable to noncontrolling interests(21.6)(26.7)(66.8)(80.9)
Less: Net and comprehensive income attributable to noncontrolling interests(21.6)(26.7)(66.8)(80.9)
Net income attributable to Encompass Health45.4100.0181.6320.6
Net and comprehensive income attributable to Encompass Health$ 45.4$ 100.0$ 181.6$ 320.6
Weighted average common shares outstanding:    
Basic (in shares)99.299.099.299.0
Diluted (in shares)100.5100.2100.3100.1
Basic earnings per share attributable to Encompass Health common shareholders:    
Continuing operations (in dollars per share)$ 0.64$ 0.76$ 1.67$ 2.32
Discontinued operations (in dollars per share)(0.19)0.240.150.90
Net income (in dollars per share)0.451.001.823.22
Diluted earnings per share attributable to Encompass Health common shareholders:    
Continuing operations (in dollars per share)0.630.761.662.31
Discontinued operations (in dollars per share)(0.18)0.240.150.89
Net income (in dollars per share)$ 0.45$ 1.00$ 1.81$ 3.20
Amounts attributable to Encompass Health common shareholders:    
Income from continuing operations$ 63.9$ 75.8$ 166.2$ 231.3
(Loss) income from discontinued operations, net of tax(18.5)24.215.489.3
Net income attributable to Encompass Health included in discontinued operations(18.5)24.215.489.3
Net income attributable to Encompass Health$ 45.4$ 100.0$ 181.6$ 320.6

EHC Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 59.8$ 49.4
Restricted cash44.362.5
Accounts receivable500.1515.8
Other current assets129.6114.9
Current assets of discontinued operations0.0178.8
Total current assets733.8921.4
Property and equipment, net2,807.42,581.2
Operating lease right-of-use assets195.7193.7
Goodwill1,247.41,237.0
Intangible assets, net284.9158.4
Other long-term assets206.6230.0
Noncurrent assets of discontinued operations0.11,543.2
Total assets[1]5,475.96,864.9
Current liabilities:  
Current portion of long-term debt26.237.8
Current operating lease liabilities22.723.5
Accounts payable134.1134.0
Accrued expenses and other current liabilities421.6421.1
Current liabilities of discontinued operations0.1132.4
Total current liabilities604.7748.8
Long-term debt, net of current portion2,719.03,240.5
Long-term operating lease liabilities183.3179.6
Deferred income tax liabilities46.723.3
Other long-term liabilities174.0172.7
Noncurrent liabilities of discontinued operations0.4100.8
Total liabilities3,728.14,465.7
Commitments and contingencies
Redeemable noncontrolling interests37.842.2
Shareholders’ equity:  
Encompass Health shareholders’ equity1,217.01,911.3
Noncontrolling interests493.0445.7
Total shareholders’ equity1,710.02,357.0
Total liabilities and shareholders' equity[1]$ 5,475.9$ 6,864.9
[1]Our consolidated assets as of September 30, 2022 and December 31, 2021 include total assets of variable interest entities of $207.7 million and $226.2 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of September 30, 2022 and December 31, 2021 include total liabilities of the variable interest entities of $35.4 million and $38.2 million, respectively. See Note 4, Variable Interest Entities.